Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratracheal budesonide with surfactant to prevent bronchopulmonary dysplasia in very preterm infants
2024-519980-16-00Phase 3Completed
- Sponsor
- IDIBAPS
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of budesonide in bronchopulmonary dysplasia (BPD) and respiratory distress syndrome (RDS) (2 arms), sponsored by IDIBAPS. Primary endpoints: Primary efficacy endpoint and Primary safety endpoints. Started Jan 2025; status: completed.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on 2024-519980-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519980-16-00.